COVID-19 Impact on Global Over The Counter (OTC) Drugs Market Insights, Forecast to 2026
Over The Counter (OTC) Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Over The Counter (OTC) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Over The Counter (OTC) Drugs market is segmented into
The Over The Counter (OTC) Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Over The Counter (OTC) Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Over The Counter (OTC) Drugs Market Share Analysis
Over The Counter (OTC) Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Over The Counter (OTC) Drugs business, the date to enter into the Over The Counter (OTC) Drugs market, Over The Counter (OTC) Drugs product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Over The Counter (OTC) Drugs market is segmented into
- Analgesics
- Dermatology Products
- Gastrointestinal Products
- Vitamins, Mineral, and Supplements (VMS)
- Weight Loss/Dietary Products
- Ophthalmic Products
- Sleeping Aids
- Others
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacy
- Others
The Over The Counter (OTC) Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Over The Counter (OTC) Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Over The Counter (OTC) Drugs Market Share Analysis
Over The Counter (OTC) Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Over The Counter (OTC) Drugs business, the date to enter into the Over The Counter (OTC) Drugs market, Over The Counter (OTC) Drugs product introduction, recent developments, etc.
The major vendors covered:
- Bayer AG
- Boehringer Ingelheim
- GlaxoSmithKline PLC
- Johnson & Johnson
- Novartis International AG
- Pfizer,Inc.
- PGT healthcare
- Sanofi S.A
- Takeda
1 STUDY COVERAGE
1.1 Over The Counter (OTC) Drugs Product Introduction
1.2 Market Segments
1.3 Key Over The Counter (OTC) Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Over The Counter (OTC) Drugs Market Size Growth Rate by Type
1.4.2 Analgesics
1.4.3 Dermatology Products
1.4.4 Gastrointestinal Products
1.4.5 Vitamins, Mineral, and Supplements (VMS)
1.4.6 Weight Loss/Dietary Products
1.4.7 Ophthalmic Products
1.4.8 Sleeping Aids
1.4.9 Others
1.5 Market by Application
1.5.1 Global Over The Counter (OTC) Drugs Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacy
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Over The Counter (OTC) Drugs Industry Impact
1.6.1 How the Covid-19 is Affecting the Over The Counter (OTC) Drugs Industry
1.6.1.1 Over The Counter (OTC) Drugs Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Over The Counter (OTC) Drugs Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Over The Counter (OTC) Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Over The Counter (OTC) Drugs Market Size Estimates and Forecasts
2.1.1 Global Over The Counter (OTC) Drugs Revenue 2015-2026
2.1.2 Global Over The Counter (OTC) Drugs Sales 2015-2026
2.2 Over The Counter (OTC) Drugs Market Size by Region: 2020 Versus 2026
2.2.1 Global Over The Counter (OTC) Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Over The Counter (OTC) Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL OVER THE COUNTER (OTC) DRUGS COMPETITOR LANDSCAPE BY PLAYERS
3.1 Over The Counter (OTC) Drugs Sales by Manufacturers
3.1.1 Over The Counter (OTC) Drugs Sales by Manufacturers (2015-2020)
3.1.2 Over The Counter (OTC) Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Over The Counter (OTC) Drugs Revenue by Manufacturers
3.2.1 Over The Counter (OTC) Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Over The Counter (OTC) Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Over The Counter (OTC) Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Over The Counter (OTC) Drugs Revenue in 2019
3.2.5 Global Over The Counter (OTC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Over The Counter (OTC) Drugs Price by Manufacturers
3.4 Over The Counter (OTC) Drugs Manufacturing Base Distribution, Product Types
3.4.1 Over The Counter (OTC) Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Over The Counter (OTC) Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Over The Counter (OTC) Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Over The Counter (OTC) Drugs Market Size by Type (2015-2020)
4.1.1 Global Over The Counter (OTC) Drugs Sales by Type (2015-2020)
4.1.2 Global Over The Counter (OTC) Drugs Revenue by Type (2015-2020)
4.1.3 Over The Counter (OTC) Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Over The Counter (OTC) Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Over The Counter (OTC) Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Over The Counter (OTC) Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Over The Counter (OTC) Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Over The Counter (OTC) Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Over The Counter (OTC) Drugs Market Size by Application (2015-2020)
5.1.1 Global Over The Counter (OTC) Drugs Sales by Application (2015-2020)
5.1.2 Global Over The Counter (OTC) Drugs Revenue by Application (2015-2020)
5.1.3 Over The Counter (OTC) Drugs Price by Application (2015-2020)
5.2 Over The Counter (OTC) Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Over The Counter (OTC) Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Over The Counter (OTC) Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Over The Counter (OTC) Drugs Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Over The Counter (OTC) Drugs by Country
6.1.1 North America Over The Counter (OTC) Drugs Sales by Country
6.1.2 North America Over The Counter (OTC) Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Over The Counter (OTC) Drugs Market Facts & Figures by Type
6.3 North America Over The Counter (OTC) Drugs Market Facts & Figures by Application
7 EUROPE
7.1 Europe Over The Counter (OTC) Drugs by Country
7.1.1 Europe Over The Counter (OTC) Drugs Sales by Country
7.1.2 Europe Over The Counter (OTC) Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Over The Counter (OTC) Drugs Market Facts & Figures by Type
7.3 Europe Over The Counter (OTC) Drugs Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Over The Counter (OTC) Drugs by Region
8.1.1 Asia Pacific Over The Counter (OTC) Drugs Sales by Region
8.1.2 Asia Pacific Over The Counter (OTC) Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Over The Counter (OTC) Drugs Market Facts & Figures by Type
8.3 Asia Pacific Over The Counter (OTC) Drugs Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Over The Counter (OTC) Drugs by Country
9.1.1 Latin America Over The Counter (OTC) Drugs Sales by Country
9.1.2 Latin America Over The Counter (OTC) Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Over The Counter (OTC) Drugs Market Facts & Figures by Type
9.3 Central & South America Over The Counter (OTC) Drugs Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Over The Counter (OTC) Drugs by Country
10.1.1 Middle East and Africa Over The Counter (OTC) Drugs Sales by Country
10.1.2 Middle East and Africa Over The Counter (OTC) Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Over The Counter (OTC) Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Over The Counter (OTC) Drugs Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Bayer AG
11.1.1 Bayer AG Corporation Information
11.1.2 Bayer AG Description, Business Overview and Total Revenue
11.1.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer AG Over The Counter (OTC) Drugs Products Offered
11.1.5 Bayer AG Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Corporation Information
11.2.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
11.2.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Boehringer Ingelheim Over The Counter (OTC) Drugs Products Offered
11.2.5 Boehringer Ingelheim Recent Development
11.3 GlaxoSmithKline PLC
11.3.1 GlaxoSmithKline PLC Corporation Information
11.3.2 GlaxoSmithKline PLC Description, Business Overview and Total Revenue
11.3.3 GlaxoSmithKline PLC Sales, Revenue and Gross Margin (2015-2020)
11.3.4 GlaxoSmithKline PLC Over The Counter (OTC) Drugs Products Offered
11.3.5 GlaxoSmithKline PLC Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Description, Business Overview and Total Revenue
11.4.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Johnson & Johnson Over The Counter (OTC) Drugs Products Offered
11.4.5 Johnson & Johnson Recent Development
11.5 Novartis International AG
11.5.1 Novartis International AG Corporation Information
11.5.2 Novartis International AG Description, Business Overview and Total Revenue
11.5.3 Novartis International AG Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Novartis International AG Over The Counter (OTC) Drugs Products Offered
11.5.5 Novartis International AG Recent Development
11.6 Pfizer,Inc.
11.6.1 Pfizer,Inc. Corporation Information
11.6.2 Pfizer,Inc. Description, Business Overview and Total Revenue
11.6.3 Pfizer,Inc. Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Pfizer,Inc. Over The Counter (OTC) Drugs Products Offered
11.6.5 Pfizer,Inc. Recent Development
11.7 PGT healthcare
11.7.1 PGT healthcare Corporation Information
11.7.2 PGT healthcare Description, Business Overview and Total Revenue
11.7.3 PGT healthcare Sales, Revenue and Gross Margin (2015-2020)
11.7.4 PGT healthcare Over The Counter (OTC) Drugs Products Offered
11.7.5 PGT healthcare Recent Development
11.8 Sanofi S.A
11.8.1 Sanofi S.A Corporation Information
11.8.2 Sanofi S.A Description, Business Overview and Total Revenue
11.8.3 Sanofi S.A Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Sanofi S.A Over The Counter (OTC) Drugs Products Offered
11.8.5 Sanofi S.A Recent Development
11.9 Takeda
11.9.1 Takeda Corporation Information
11.9.2 Takeda Description, Business Overview and Total Revenue
11.9.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Takeda Over The Counter (OTC) Drugs Products Offered
11.9.5 Takeda Recent Development
11.1 Bayer AG
11.1.1 Bayer AG Corporation Information
11.1.2 Bayer AG Description, Business Overview and Total Revenue
11.1.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer AG Over The Counter (OTC) Drugs Products Offered
11.1.5 Bayer AG Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Over The Counter (OTC) Drugs Market Estimates and Projections by Region
12.1.1 Global Over The Counter (OTC) Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Over The Counter (OTC) Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Over The Counter (OTC) Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Over The Counter (OTC) Drugs Sales Forecast (2021-2026)
12.2.2 North America: Over The Counter (OTC) Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Over The Counter (OTC) Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Over The Counter (OTC) Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Over The Counter (OTC) Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Over The Counter (OTC) Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Over The Counter (OTC) Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Over The Counter (OTC) Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Over The Counter (OTC) Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Over The Counter (OTC) Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Over The Counter (OTC) Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Over The Counter (OTC) Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Over The Counter (OTC) Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Over The Counter (OTC) Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Over The Counter (OTC) Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Over The Counter (OTC) Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Over The Counter (OTC) Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Over The Counter (OTC) Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Over The Counter (OTC) Drugs Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Over The Counter (OTC) Drugs Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Over The Counter (OTC) Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Over The Counter (OTC) Drugs Product Introduction
1.2 Market Segments
1.3 Key Over The Counter (OTC) Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Over The Counter (OTC) Drugs Market Size Growth Rate by Type
1.4.2 Analgesics
1.4.3 Dermatology Products
1.4.4 Gastrointestinal Products
1.4.5 Vitamins, Mineral, and Supplements (VMS)
1.4.6 Weight Loss/Dietary Products
1.4.7 Ophthalmic Products
1.4.8 Sleeping Aids
1.4.9 Others
1.5 Market by Application
1.5.1 Global Over The Counter (OTC) Drugs Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacy
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Over The Counter (OTC) Drugs Industry Impact
1.6.1 How the Covid-19 is Affecting the Over The Counter (OTC) Drugs Industry
1.6.1.1 Over The Counter (OTC) Drugs Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Over The Counter (OTC) Drugs Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Over The Counter (OTC) Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Over The Counter (OTC) Drugs Market Size Estimates and Forecasts
2.1.1 Global Over The Counter (OTC) Drugs Revenue 2015-2026
2.1.2 Global Over The Counter (OTC) Drugs Sales 2015-2026
2.2 Over The Counter (OTC) Drugs Market Size by Region: 2020 Versus 2026
2.2.1 Global Over The Counter (OTC) Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Over The Counter (OTC) Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL OVER THE COUNTER (OTC) DRUGS COMPETITOR LANDSCAPE BY PLAYERS
3.1 Over The Counter (OTC) Drugs Sales by Manufacturers
3.1.1 Over The Counter (OTC) Drugs Sales by Manufacturers (2015-2020)
3.1.2 Over The Counter (OTC) Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Over The Counter (OTC) Drugs Revenue by Manufacturers
3.2.1 Over The Counter (OTC) Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Over The Counter (OTC) Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Over The Counter (OTC) Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Over The Counter (OTC) Drugs Revenue in 2019
3.2.5 Global Over The Counter (OTC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Over The Counter (OTC) Drugs Price by Manufacturers
3.4 Over The Counter (OTC) Drugs Manufacturing Base Distribution, Product Types
3.4.1 Over The Counter (OTC) Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Over The Counter (OTC) Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Over The Counter (OTC) Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Over The Counter (OTC) Drugs Market Size by Type (2015-2020)
4.1.1 Global Over The Counter (OTC) Drugs Sales by Type (2015-2020)
4.1.2 Global Over The Counter (OTC) Drugs Revenue by Type (2015-2020)
4.1.3 Over The Counter (OTC) Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Over The Counter (OTC) Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Over The Counter (OTC) Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Over The Counter (OTC) Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Over The Counter (OTC) Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Over The Counter (OTC) Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Over The Counter (OTC) Drugs Market Size by Application (2015-2020)
5.1.1 Global Over The Counter (OTC) Drugs Sales by Application (2015-2020)
5.1.2 Global Over The Counter (OTC) Drugs Revenue by Application (2015-2020)
5.1.3 Over The Counter (OTC) Drugs Price by Application (2015-2020)
5.2 Over The Counter (OTC) Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Over The Counter (OTC) Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Over The Counter (OTC) Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Over The Counter (OTC) Drugs Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Over The Counter (OTC) Drugs by Country
6.1.1 North America Over The Counter (OTC) Drugs Sales by Country
6.1.2 North America Over The Counter (OTC) Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Over The Counter (OTC) Drugs Market Facts & Figures by Type
6.3 North America Over The Counter (OTC) Drugs Market Facts & Figures by Application
7 EUROPE
7.1 Europe Over The Counter (OTC) Drugs by Country
7.1.1 Europe Over The Counter (OTC) Drugs Sales by Country
7.1.2 Europe Over The Counter (OTC) Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Over The Counter (OTC) Drugs Market Facts & Figures by Type
7.3 Europe Over The Counter (OTC) Drugs Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Over The Counter (OTC) Drugs by Region
8.1.1 Asia Pacific Over The Counter (OTC) Drugs Sales by Region
8.1.2 Asia Pacific Over The Counter (OTC) Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Over The Counter (OTC) Drugs Market Facts & Figures by Type
8.3 Asia Pacific Over The Counter (OTC) Drugs Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Over The Counter (OTC) Drugs by Country
9.1.1 Latin America Over The Counter (OTC) Drugs Sales by Country
9.1.2 Latin America Over The Counter (OTC) Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Over The Counter (OTC) Drugs Market Facts & Figures by Type
9.3 Central & South America Over The Counter (OTC) Drugs Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Over The Counter (OTC) Drugs by Country
10.1.1 Middle East and Africa Over The Counter (OTC) Drugs Sales by Country
10.1.2 Middle East and Africa Over The Counter (OTC) Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Over The Counter (OTC) Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Over The Counter (OTC) Drugs Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Bayer AG
11.1.1 Bayer AG Corporation Information
11.1.2 Bayer AG Description, Business Overview and Total Revenue
11.1.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer AG Over The Counter (OTC) Drugs Products Offered
11.1.5 Bayer AG Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Corporation Information
11.2.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
11.2.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Boehringer Ingelheim Over The Counter (OTC) Drugs Products Offered
11.2.5 Boehringer Ingelheim Recent Development
11.3 GlaxoSmithKline PLC
11.3.1 GlaxoSmithKline PLC Corporation Information
11.3.2 GlaxoSmithKline PLC Description, Business Overview and Total Revenue
11.3.3 GlaxoSmithKline PLC Sales, Revenue and Gross Margin (2015-2020)
11.3.4 GlaxoSmithKline PLC Over The Counter (OTC) Drugs Products Offered
11.3.5 GlaxoSmithKline PLC Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Description, Business Overview and Total Revenue
11.4.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Johnson & Johnson Over The Counter (OTC) Drugs Products Offered
11.4.5 Johnson & Johnson Recent Development
11.5 Novartis International AG
11.5.1 Novartis International AG Corporation Information
11.5.2 Novartis International AG Description, Business Overview and Total Revenue
11.5.3 Novartis International AG Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Novartis International AG Over The Counter (OTC) Drugs Products Offered
11.5.5 Novartis International AG Recent Development
11.6 Pfizer,Inc.
11.6.1 Pfizer,Inc. Corporation Information
11.6.2 Pfizer,Inc. Description, Business Overview and Total Revenue
11.6.3 Pfizer,Inc. Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Pfizer,Inc. Over The Counter (OTC) Drugs Products Offered
11.6.5 Pfizer,Inc. Recent Development
11.7 PGT healthcare
11.7.1 PGT healthcare Corporation Information
11.7.2 PGT healthcare Description, Business Overview and Total Revenue
11.7.3 PGT healthcare Sales, Revenue and Gross Margin (2015-2020)
11.7.4 PGT healthcare Over The Counter (OTC) Drugs Products Offered
11.7.5 PGT healthcare Recent Development
11.8 Sanofi S.A
11.8.1 Sanofi S.A Corporation Information
11.8.2 Sanofi S.A Description, Business Overview and Total Revenue
11.8.3 Sanofi S.A Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Sanofi S.A Over The Counter (OTC) Drugs Products Offered
11.8.5 Sanofi S.A Recent Development
11.9 Takeda
11.9.1 Takeda Corporation Information
11.9.2 Takeda Description, Business Overview and Total Revenue
11.9.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Takeda Over The Counter (OTC) Drugs Products Offered
11.9.5 Takeda Recent Development
11.1 Bayer AG
11.1.1 Bayer AG Corporation Information
11.1.2 Bayer AG Description, Business Overview and Total Revenue
11.1.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer AG Over The Counter (OTC) Drugs Products Offered
11.1.5 Bayer AG Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Over The Counter (OTC) Drugs Market Estimates and Projections by Region
12.1.1 Global Over The Counter (OTC) Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Over The Counter (OTC) Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Over The Counter (OTC) Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Over The Counter (OTC) Drugs Sales Forecast (2021-2026)
12.2.2 North America: Over The Counter (OTC) Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Over The Counter (OTC) Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Over The Counter (OTC) Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Over The Counter (OTC) Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Over The Counter (OTC) Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Over The Counter (OTC) Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Over The Counter (OTC) Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Over The Counter (OTC) Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Over The Counter (OTC) Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Over The Counter (OTC) Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Over The Counter (OTC) Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Over The Counter (OTC) Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Over The Counter (OTC) Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Over The Counter (OTC) Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Over The Counter (OTC) Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Over The Counter (OTC) Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Over The Counter (OTC) Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Over The Counter (OTC) Drugs Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Over The Counter (OTC) Drugs Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Over The Counter (OTC) Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Over The Counter (OTC) Drugs Market Segments
Table 2. Ranking of Global Top Over The Counter (OTC) Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Over The Counter (OTC) Drugs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Analgesics
Table 5. Major Manufacturers of Dermatology Products
Table 6. Major Manufacturers of Gastrointestinal Products
Table 7. Major Manufacturers of Vitamins, Mineral, and Supplements (VMS)
Table 8. Major Manufacturers of Weight Loss/Dietary Products
Table 9. Major Manufacturers of Ophthalmic Products
Table 10. Major Manufacturers of Sleeping Aids
Table 11. Major Manufacturers of Others
Table 12. COVID-19 Impact Global Market: (Four Over The Counter (OTC) Drugs Market Size Forecast Scenarios)
Table 13. Opportunities and Trends for Over The Counter (OTC) Drugs Players in the COVID-19 Landscape
Table 14. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 15. Key Regions/Countries Measures against Covid-19 Impact
Table 16. Proposal for Over The Counter (OTC) Drugs Players to Combat Covid-19 Impact
Table 17. Global Over The Counter (OTC) Drugs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 18. Global Over The Counter (OTC) Drugs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 19. Global Over The Counter (OTC) Drugs Sales by Regions 2015-2020 (K MT)
Table 20. Global Over The Counter (OTC) Drugs Sales Market Share by Regions (2015-2020)
Table 21. Global Over The Counter (OTC) Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 22. Global Over The Counter (OTC) Drugs Sales by Manufacturers (2015-2020) (K MT)
Table 23. Global Over The Counter (OTC) Drugs Sales Share by Manufacturers (2015-2020)
Table 24. Global Over The Counter (OTC) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 25. Global Over The Counter (OTC) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Over The Counter (OTC) Drugs as of 2019)
Table 26. Over The Counter (OTC) Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 27. Over The Counter (OTC) Drugs Revenue Share by Manufacturers (2015-2020)
Table 28. Key Manufacturers Over The Counter (OTC) Drugs Price (2015-2020) (USD/MT)
Table 29. Over The Counter (OTC) Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 30. Manufacturers Over The Counter (OTC) Drugs Product Type
Table 31. Date of International Manufacturers Enter into Over The Counter (OTC) Drugs Market
Table 32. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 33. Global Over The Counter (OTC) Drugs Sales by Type (2015-2020) (K MT)
Table 34. Global Over The Counter (OTC) Drugs Sales Share by Type (2015-2020)
Table 35. Global Over The Counter (OTC) Drugs Revenue by Type (2015-2020) (US$ Million)
Table 36. Global Over The Counter (OTC) Drugs Revenue Share by Type (2015-2020)
Table 37. Over The Counter (OTC) Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 38. Global Over The Counter (OTC) Drugs Sales by Application (2015-2020) (K MT)
Table 39. Global Over The Counter (OTC) Drugs Sales Share by Application (2015-2020)
Table 40. North America Over The Counter (OTC) Drugs Sales by Country (2015-2020) (K MT)
Table 41. North America Over The Counter (OTC) Drugs Sales Market Share by Country (2015-2020)
Table 42. North America Over The Counter (OTC) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 43. North America Over The Counter (OTC) Drugs Revenue Market Share by Country (2015-2020)
Table 44. North America Over The Counter (OTC) Drugs Sales by Type (2015-2020) (K MT)
Table 45. North America Over The Counter (OTC) Drugs Sales Market Share by Type (2015-2020)
Table 46. North America Over The Counter (OTC) Drugs Sales by Application (2015-2020) (K MT)
Table 47. North America Over The Counter (OTC) Drugs Sales Market Share by Application (2015-2020)
Table 48. Europe Over The Counter (OTC) Drugs Sales by Country (2015-2020) (K MT)
Table 49. Europe Over The Counter (OTC) Drugs Sales Market Share by Country (2015-2020)
Table 50. Europe Over The Counter (OTC) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 51. Europe Over The Counter (OTC) Drugs Revenue Market Share by Country (2015-2020)
Table 52. Europe Over The Counter (OTC) Drugs Sales by Type (2015-2020) (K MT)
Table 53. Europe Over The Counter (OTC) Drugs Sales Market Share by Type (2015-2020)
Table 54. Europe Over The Counter (OTC) Drugs Sales by Application (2015-2020) (K MT)
Table 55. Europe Over The Counter (OTC) Drugs Sales Market Share by Application (2015-2020)
Table 56. Asia Pacific Over The Counter (OTC) Drugs Sales by Region (2015-2020) (K MT)
Table 57. Asia Pacific Over The Counter (OTC) Drugs Sales Market Share by Region (2015-2020)
Table 58. Asia Pacific Over The Counter (OTC) Drugs Revenue by Region (2015-2020) (US$ Million)
Table 59. Asia Pacific Over The Counter (OTC) Drugs Revenue Market Share by Region (2015-2020)
Table 60. Asia Pacific Over The Counter (OTC) Drugs Sales by Type (2015-2020) (K MT)
Table 61. Asia Pacific Over The Counter (OTC) Drugs Sales Market Share by Type (2015-2020)
Table 62. Asia Pacific Over The Counter (OTC) Drugs Sales by Application (2015-2020) (K MT)
Table 63. Asia Pacific Over The Counter (OTC) Drugs Sales Market Share by Application (2015-2020)
Table 64. Latin America Over The Counter (OTC) Drugs Sales by Country (2015-2020) (K MT)
Table 65. Latin America Over The Counter (OTC) Drugs Sales Market Share by Country (2015-2020)
Table 66. Latin Americaa Over The Counter (OTC) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 67. Latin America Over The Counter (OTC) Drugs Revenue Market Share by Country (2015-2020)
Table 68. Latin America Over The Counter (OTC) Drugs Sales by Type (2015-2020) (K MT)
Table 69. Latin America Over The Counter (OTC) Drugs Sales Market Share by Type (2015-2020)
Table 70. Latin America Over The Counter (OTC) Drugs Sales by Application (2015-2020) (K MT)
Table 71. Latin America Over The Counter (OTC) Drugs Sales Market Share by Application (2015-2020)
Table 72. Middle East and Africa Over The Counter (OTC) Drugs Sales by Country (2015-2020) (K MT)
Table 73. Middle East and Africa Over The Counter (OTC) Drugs Sales Market Share by Country (2015-2020)
Table 74. Middle East and Africa Over The Counter (OTC) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 75. Middle East and Africa Over The Counter (OTC) Drugs Revenue Market Share by Country (2015-2020)
Table 76. Middle East and Africa Over The Counter (OTC) Drugs Sales by Type (2015-2020) (K MT)
Table 77. Middle East and Africa Over The Counter (OTC) Drugs Sales Market Share by Type (2015-2020)
Table 78. Middle East and Africa Over The Counter (OTC) Drugs Sales by Application (2015-2020) (K MT)
Table 79. Middle East and Africa Over The Counter (OTC) Drugs Sales Market Share by Application (2015-2020)
Table 80. Bayer AG Corporation Information
Table 81. Bayer AG Description and Major Businesses
Table 82. Bayer AG Over The Counter (OTC) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Bayer AG Product
Table 84. Bayer AG Recent Development
Table 85. Boehringer Ingelheim Corporation Information
Table 86. Boehringer Ingelheim Description and Major Businesses
Table 87. Boehringer Ingelheim Over The Counter (OTC) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Boehringer Ingelheim Product
Table 89. Boehringer Ingelheim Recent Development
Table 90. GlaxoSmithKline PLC Corporation Information
Table 91. GlaxoSmithKline PLC Description and Major Businesses
Table 92. GlaxoSmithKline PLC Over The Counter (OTC) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. GlaxoSmithKline PLC Product
Table 94. GlaxoSmithKline PLC Recent Development
Table 95. Johnson & Johnson Corporation Information
Table 96. Johnson & Johnson Description and Major Businesses
Table 97. Johnson & Johnson Over The Counter (OTC) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Johnson & Johnson Product
Table 99. Johnson & Johnson Recent Development
Table 100. Novartis International AG Corporation Information
Table 101. Novartis International AG Description and Major Businesses
Table 102. Novartis International AG Over The Counter (OTC) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Novartis International AG Product
Table 104. Novartis International AG Recent Development
Table 105. Pfizer,Inc. Corporation Information
Table 106. Pfizer,Inc. Description and Major Businesses
Table 107. Pfizer,Inc. Over The Counter (OTC) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Pfizer,Inc. Product
Table 109. Pfizer,Inc. Recent Development
Table 110. PGT healthcare Corporation Information
Table 111. PGT healthcare Description and Major Businesses
Table 112. PGT healthcare Over The Counter (OTC) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. PGT healthcare Product
Table 114. PGT healthcare Recent Development
Table 115. Sanofi S.A Corporation Information
Table 116. Sanofi S.A Description and Major Businesses
Table 117. Sanofi S.A Over The Counter (OTC) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 118. Sanofi S.A Product
Table 119. Sanofi S.A Recent Development
Table 120. Takeda Corporation Information
Table 121. Takeda Description and Major Businesses
Table 122. Takeda Over The Counter (OTC) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Takeda Product
Table 124. Takeda Recent Development
Table 125. Global Over The Counter (OTC) Drugs Sales Forecast by Regions (2021-2026) (K MT)
Table 126. Global Over The Counter (OTC) Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 127. Global Over The Counter (OTC) Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 128. Global Over The Counter (OTC) Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 129. North America: Over The Counter (OTC) Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 130. North America: Over The Counter (OTC) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Europe: Over The Counter (OTC) Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 132. Europe: Over The Counter (OTC) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Asia Pacific: Over The Counter (OTC) Drugs Sales Forecast by Region (2021-2026) (K MT)
Table 134. Asia Pacific: Over The Counter (OTC) Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 135. Latin America: Over The Counter (OTC) Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 136. Latin America: Over The Counter (OTC) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Middle East and Africa: Over The Counter (OTC) Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 138. Middle East and Africa: Over The Counter (OTC) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 140. Key Challenges
Table 141. Market Risks
Table 142. Main Points Interviewed from Key Over The Counter (OTC) Drugs Players
Table 143. Over The Counter (OTC) Drugs Customers List
Table 144. Over The Counter (OTC) Drugs Distributors List
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
Table 1. Over The Counter (OTC) Drugs Market Segments
Table 2. Ranking of Global Top Over The Counter (OTC) Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Over The Counter (OTC) Drugs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Analgesics
Table 5. Major Manufacturers of Dermatology Products
Table 6. Major Manufacturers of Gastrointestinal Products
Table 7. Major Manufacturers of Vitamins, Mineral, and Supplements (VMS)
Table 8. Major Manufacturers of Weight Loss/Dietary Products
Table 9. Major Manufacturers of Ophthalmic Products
Table 10. Major Manufacturers of Sleeping Aids
Table 11. Major Manufacturers of Others
Table 12. COVID-19 Impact Global Market: (Four Over The Counter (OTC) Drugs Market Size Forecast Scenarios)
Table 13. Opportunities and Trends for Over The Counter (OTC) Drugs Players in the COVID-19 Landscape
Table 14. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 15. Key Regions/Countries Measures against Covid-19 Impact
Table 16. Proposal for Over The Counter (OTC) Drugs Players to Combat Covid-19 Impact
Table 17. Global Over The Counter (OTC) Drugs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 18. Global Over The Counter (OTC) Drugs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 19. Global Over The Counter (OTC) Drugs Sales by Regions 2015-2020 (K MT)
Table 20. Global Over The Counter (OTC) Drugs Sales Market Share by Regions (2015-2020)
Table 21. Global Over The Counter (OTC) Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 22. Global Over The Counter (OTC) Drugs Sales by Manufacturers (2015-2020) (K MT)
Table 23. Global Over The Counter (OTC) Drugs Sales Share by Manufacturers (2015-2020)
Table 24. Global Over The Counter (OTC) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 25. Global Over The Counter (OTC) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Over The Counter (OTC) Drugs as of 2019)
Table 26. Over The Counter (OTC) Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 27. Over The Counter (OTC) Drugs Revenue Share by Manufacturers (2015-2020)
Table 28. Key Manufacturers Over The Counter (OTC) Drugs Price (2015-2020) (USD/MT)
Table 29. Over The Counter (OTC) Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 30. Manufacturers Over The Counter (OTC) Drugs Product Type
Table 31. Date of International Manufacturers Enter into Over The Counter (OTC) Drugs Market
Table 32. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 33. Global Over The Counter (OTC) Drugs Sales by Type (2015-2020) (K MT)
Table 34. Global Over The Counter (OTC) Drugs Sales Share by Type (2015-2020)
Table 35. Global Over The Counter (OTC) Drugs Revenue by Type (2015-2020) (US$ Million)
Table 36. Global Over The Counter (OTC) Drugs Revenue Share by Type (2015-2020)
Table 37. Over The Counter (OTC) Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 38. Global Over The Counter (OTC) Drugs Sales by Application (2015-2020) (K MT)
Table 39. Global Over The Counter (OTC) Drugs Sales Share by Application (2015-2020)
Table 40. North America Over The Counter (OTC) Drugs Sales by Country (2015-2020) (K MT)
Table 41. North America Over The Counter (OTC) Drugs Sales Market Share by Country (2015-2020)
Table 42. North America Over The Counter (OTC) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 43. North America Over The Counter (OTC) Drugs Revenue Market Share by Country (2015-2020)
Table 44. North America Over The Counter (OTC) Drugs Sales by Type (2015-2020) (K MT)
Table 45. North America Over The Counter (OTC) Drugs Sales Market Share by Type (2015-2020)
Table 46. North America Over The Counter (OTC) Drugs Sales by Application (2015-2020) (K MT)
Table 47. North America Over The Counter (OTC) Drugs Sales Market Share by Application (2015-2020)
Table 48. Europe Over The Counter (OTC) Drugs Sales by Country (2015-2020) (K MT)
Table 49. Europe Over The Counter (OTC) Drugs Sales Market Share by Country (2015-2020)
Table 50. Europe Over The Counter (OTC) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 51. Europe Over The Counter (OTC) Drugs Revenue Market Share by Country (2015-2020)
Table 52. Europe Over The Counter (OTC) Drugs Sales by Type (2015-2020) (K MT)
Table 53. Europe Over The Counter (OTC) Drugs Sales Market Share by Type (2015-2020)
Table 54. Europe Over The Counter (OTC) Drugs Sales by Application (2015-2020) (K MT)
Table 55. Europe Over The Counter (OTC) Drugs Sales Market Share by Application (2015-2020)
Table 56. Asia Pacific Over The Counter (OTC) Drugs Sales by Region (2015-2020) (K MT)
Table 57. Asia Pacific Over The Counter (OTC) Drugs Sales Market Share by Region (2015-2020)
Table 58. Asia Pacific Over The Counter (OTC) Drugs Revenue by Region (2015-2020) (US$ Million)
Table 59. Asia Pacific Over The Counter (OTC) Drugs Revenue Market Share by Region (2015-2020)
Table 60. Asia Pacific Over The Counter (OTC) Drugs Sales by Type (2015-2020) (K MT)
Table 61. Asia Pacific Over The Counter (OTC) Drugs Sales Market Share by Type (2015-2020)
Table 62. Asia Pacific Over The Counter (OTC) Drugs Sales by Application (2015-2020) (K MT)
Table 63. Asia Pacific Over The Counter (OTC) Drugs Sales Market Share by Application (2015-2020)
Table 64. Latin America Over The Counter (OTC) Drugs Sales by Country (2015-2020) (K MT)
Table 65. Latin America Over The Counter (OTC) Drugs Sales Market Share by Country (2015-2020)
Table 66. Latin Americaa Over The Counter (OTC) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 67. Latin America Over The Counter (OTC) Drugs Revenue Market Share by Country (2015-2020)
Table 68. Latin America Over The Counter (OTC) Drugs Sales by Type (2015-2020) (K MT)
Table 69. Latin America Over The Counter (OTC) Drugs Sales Market Share by Type (2015-2020)
Table 70. Latin America Over The Counter (OTC) Drugs Sales by Application (2015-2020) (K MT)
Table 71. Latin America Over The Counter (OTC) Drugs Sales Market Share by Application (2015-2020)
Table 72. Middle East and Africa Over The Counter (OTC) Drugs Sales by Country (2015-2020) (K MT)
Table 73. Middle East and Africa Over The Counter (OTC) Drugs Sales Market Share by Country (2015-2020)
Table 74. Middle East and Africa Over The Counter (OTC) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 75. Middle East and Africa Over The Counter (OTC) Drugs Revenue Market Share by Country (2015-2020)
Table 76. Middle East and Africa Over The Counter (OTC) Drugs Sales by Type (2015-2020) (K MT)
Table 77. Middle East and Africa Over The Counter (OTC) Drugs Sales Market Share by Type (2015-2020)
Table 78. Middle East and Africa Over The Counter (OTC) Drugs Sales by Application (2015-2020) (K MT)
Table 79. Middle East and Africa Over The Counter (OTC) Drugs Sales Market Share by Application (2015-2020)
Table 80. Bayer AG Corporation Information
Table 81. Bayer AG Description and Major Businesses
Table 82. Bayer AG Over The Counter (OTC) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Bayer AG Product
Table 84. Bayer AG Recent Development
Table 85. Boehringer Ingelheim Corporation Information
Table 86. Boehringer Ingelheim Description and Major Businesses
Table 87. Boehringer Ingelheim Over The Counter (OTC) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Boehringer Ingelheim Product
Table 89. Boehringer Ingelheim Recent Development
Table 90. GlaxoSmithKline PLC Corporation Information
Table 91. GlaxoSmithKline PLC Description and Major Businesses
Table 92. GlaxoSmithKline PLC Over The Counter (OTC) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. GlaxoSmithKline PLC Product
Table 94. GlaxoSmithKline PLC Recent Development
Table 95. Johnson & Johnson Corporation Information
Table 96. Johnson & Johnson Description and Major Businesses
Table 97. Johnson & Johnson Over The Counter (OTC) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Johnson & Johnson Product
Table 99. Johnson & Johnson Recent Development
Table 100. Novartis International AG Corporation Information
Table 101. Novartis International AG Description and Major Businesses
Table 102. Novartis International AG Over The Counter (OTC) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Novartis International AG Product
Table 104. Novartis International AG Recent Development
Table 105. Pfizer,Inc. Corporation Information
Table 106. Pfizer,Inc. Description and Major Businesses
Table 107. Pfizer,Inc. Over The Counter (OTC) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Pfizer,Inc. Product
Table 109. Pfizer,Inc. Recent Development
Table 110. PGT healthcare Corporation Information
Table 111. PGT healthcare Description and Major Businesses
Table 112. PGT healthcare Over The Counter (OTC) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. PGT healthcare Product
Table 114. PGT healthcare Recent Development
Table 115. Sanofi S.A Corporation Information
Table 116. Sanofi S.A Description and Major Businesses
Table 117. Sanofi S.A Over The Counter (OTC) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 118. Sanofi S.A Product
Table 119. Sanofi S.A Recent Development
Table 120. Takeda Corporation Information
Table 121. Takeda Description and Major Businesses
Table 122. Takeda Over The Counter (OTC) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Takeda Product
Table 124. Takeda Recent Development
Table 125. Global Over The Counter (OTC) Drugs Sales Forecast by Regions (2021-2026) (K MT)
Table 126. Global Over The Counter (OTC) Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 127. Global Over The Counter (OTC) Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 128. Global Over The Counter (OTC) Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 129. North America: Over The Counter (OTC) Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 130. North America: Over The Counter (OTC) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Europe: Over The Counter (OTC) Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 132. Europe: Over The Counter (OTC) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Asia Pacific: Over The Counter (OTC) Drugs Sales Forecast by Region (2021-2026) (K MT)
Table 134. Asia Pacific: Over The Counter (OTC) Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 135. Latin America: Over The Counter (OTC) Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 136. Latin America: Over The Counter (OTC) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Middle East and Africa: Over The Counter (OTC) Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 138. Middle East and Africa: Over The Counter (OTC) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 140. Key Challenges
Table 141. Market Risks
Table 142. Main Points Interviewed from Key Over The Counter (OTC) Drugs Players
Table 143. Over The Counter (OTC) Drugs Customers List
Table 144. Over The Counter (OTC) Drugs Distributors List
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Over The Counter (OTC) Drugs Product Picture
Figure 2. Global Over The Counter (OTC) Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Analgesics Product Picture
Figure 4. Dermatology Products Product Picture
Figure 5. Gastrointestinal Products Product Picture
Figure 6. Vitamins, Mineral, and Supplements (VMS) Product Picture
Figure 7. Weight Loss/Dietary Products Product Picture
Figure 8. Ophthalmic Products Product Picture
Figure 9. Sleeping Aids Product Picture
Figure 10. Others Product Picture
Figure 11. Global Over The Counter (OTC) Drugs Sales Market Share by Application in 2020 & 2026
Figure 12. Hospital Pharmacies
Figure 13. Retail Pharmacies
Figure 14. Online Pharmacy
Figure 15. Others
Figure 16. Over The Counter (OTC) Drugs Report Years Considered
Figure 17. Global Over The Counter (OTC) Drugs Market Size 2015-2026 (US$ Million)
Figure 18. Global Over The Counter (OTC) Drugs Sales 2015-2026 (K MT)
Figure 19. Global Over The Counter (OTC) Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 20. Global Over The Counter (OTC) Drugs Sales Market Share by Region (2015-2020)
Figure 21. Global Over The Counter (OTC) Drugs Sales Market Share by Region in 2019
Figure 22. Global Over The Counter (OTC) Drugs Revenue Market Share by Region (2015-2020)
Figure 23. Global Over The Counter (OTC) Drugs Revenue Market Share by Region in 2019
Figure 24. Global Over The Counter (OTC) Drugs Sales Share by Manufacturer in 2019
Figure 25. The Top 10 and 5 Players Market Share by Over The Counter (OTC) Drugs Revenue in 2019
Figure 26. Over The Counter (OTC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Over The Counter (OTC) Drugs Sales Market Share by Type (2015-2020)
Figure 28. Global Over The Counter (OTC) Drugs Sales Market Share by Type in 2019
Figure 29. Global Over The Counter (OTC) Drugs Revenue Market Share by Type (2015-2020)
Figure 30. Global Over The Counter (OTC) Drugs Revenue Market Share by Type in 2019
Figure 31. Global Over The Counter (OTC) Drugs Market Share by Price Range (2015-2020)
Figure 32. Global Over The Counter (OTC) Drugs Sales Market Share by Application (2015-2020)
Figure 33. Global Over The Counter (OTC) Drugs Sales Market Share by Application in 2019
Figure 34. Global Over The Counter (OTC) Drugs Revenue Market Share by Application (2015-2020)
Figure 35. Global Over The Counter (OTC) Drugs Revenue Market Share by Application in 2019
Figure 36. North America Over The Counter (OTC) Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 37. North America Over The Counter (OTC) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 38. North America Over The Counter (OTC) Drugs Sales Market Share by Country in 2019
Figure 39. North America Over The Counter (OTC) Drugs Revenue Market Share by Country in 2019
Figure 40. U.S. Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 41. U.S. Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Canada Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 43. Canada Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. North America Over The Counter (OTC) Drugs Market Share by Type in 2019
Figure 45. North America Over The Counter (OTC) Drugs Market Share by Application in 2019
Figure 46. Europe Over The Counter (OTC) Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 47. Europe Over The Counter (OTC) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 48. Europe Over The Counter (OTC) Drugs Sales Market Share by Country in 2019
Figure 49. Europe Over The Counter (OTC) Drugs Revenue Market Share by Country in 2019
Figure 50. Germany Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 51. Germany Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. France Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 53. France Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. U.K. Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 55. U.K. Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Italy Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 57. Italy Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Russia Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 59. Russia Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Europe Over The Counter (OTC) Drugs Market Share by Type in 2019
Figure 61. Europe Over The Counter (OTC) Drugs Market Share by Application in 2019
Figure 62. Asia Pacific Over The Counter (OTC) Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 63. Asia Pacific Over The Counter (OTC) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 64. Asia Pacific Over The Counter (OTC) Drugs Sales Market Share by Region in 2019
Figure 65. Asia Pacific Over The Counter (OTC) Drugs Revenue Market Share by Region in 2019
Figure 66. China Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 67. China Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Japan Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 69. Japan Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. South Korea Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 71. South Korea Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. India Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 73. India Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Australia Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 75. Australia Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Taiwan Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 77. Taiwan Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Indonesia Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 79. Indonesia Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Thailand Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 81. Thailand Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Malaysia Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 83. Malaysia Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Philippines Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 85. Philippines Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Vietnam Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 87. Vietnam Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Asia Pacific Over The Counter (OTC) Drugs Market Share by Type in 2019
Figure 89. Asia Pacific Over The Counter (OTC) Drugs Market Share by Application in 2019
Figure 90. Latin America Over The Counter (OTC) Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 91. Latin America Over The Counter (OTC) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 92. Latin America Over The Counter (OTC) Drugs Sales Market Share by Country in 2019
Figure 93. Latin America Over The Counter (OTC) Drugs Revenue Market Share by Country in 2019
Figure 94. Mexico Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 95. Mexico Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Brazil Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 97. Brazil Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Argentina Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 99. Argentina Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Latin America Over The Counter (OTC) Drugs Market Share by Type in 2019
Figure 101. Latin America Over The Counter (OTC) Drugs Market Share by Application in 2019
Figure 102. Middle East and Africa Over The Counter (OTC) Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 103. Middle East and Africa Over The Counter (OTC) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 104. Middle East and Africa Over The Counter (OTC) Drugs Sales Market Share by Country in 2019
Figure 105. Middle East and Africa Over The Counter (OTC) Drugs Revenue Market Share by Country in 2019
Figure 106. Turkey Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 107. Turkey Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Saudi Arabia Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 109. Saudi Arabia Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. U.A.E Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 111. U.A.E Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 112. Middle East and Africa Over The Counter (OTC) Drugs Market Share by Type in 2019
Figure 113. Middle East and Africa Over The Counter (OTC) Drugs Market Share by Application in 2019
Figure 114. Bayer AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. GlaxoSmithKline PLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Novartis International AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Pfizer,Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. PGT healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. Sanofi S.A Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 123. North America Over The Counter (OTC) Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 124. North America Over The Counter (OTC) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Europe Over The Counter (OTC) Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 126. Europe Over The Counter (OTC) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Asia Pacific Over The Counter (OTC) Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 128. Asia Pacific Over The Counter (OTC) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Latin America Over The Counter (OTC) Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 130. Latin America Over The Counter (OTC) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 131. Middle East and Africa Over The Counter (OTC) Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 132. Middle East and Africa Over The Counter (OTC) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 133. Porter's Five Forces Analysis
Figure 134. Channels of Distribution
Figure 135. Distributors Profiles
Figure 136. Bottom-up and Top-down Approaches for This Report
Figure 137. Data Triangulation
Figure 138. Key Executives Interviewed
Figure 1. Over The Counter (OTC) Drugs Product Picture
Figure 2. Global Over The Counter (OTC) Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Analgesics Product Picture
Figure 4. Dermatology Products Product Picture
Figure 5. Gastrointestinal Products Product Picture
Figure 6. Vitamins, Mineral, and Supplements (VMS) Product Picture
Figure 7. Weight Loss/Dietary Products Product Picture
Figure 8. Ophthalmic Products Product Picture
Figure 9. Sleeping Aids Product Picture
Figure 10. Others Product Picture
Figure 11. Global Over The Counter (OTC) Drugs Sales Market Share by Application in 2020 & 2026
Figure 12. Hospital Pharmacies
Figure 13. Retail Pharmacies
Figure 14. Online Pharmacy
Figure 15. Others
Figure 16. Over The Counter (OTC) Drugs Report Years Considered
Figure 17. Global Over The Counter (OTC) Drugs Market Size 2015-2026 (US$ Million)
Figure 18. Global Over The Counter (OTC) Drugs Sales 2015-2026 (K MT)
Figure 19. Global Over The Counter (OTC) Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 20. Global Over The Counter (OTC) Drugs Sales Market Share by Region (2015-2020)
Figure 21. Global Over The Counter (OTC) Drugs Sales Market Share by Region in 2019
Figure 22. Global Over The Counter (OTC) Drugs Revenue Market Share by Region (2015-2020)
Figure 23. Global Over The Counter (OTC) Drugs Revenue Market Share by Region in 2019
Figure 24. Global Over The Counter (OTC) Drugs Sales Share by Manufacturer in 2019
Figure 25. The Top 10 and 5 Players Market Share by Over The Counter (OTC) Drugs Revenue in 2019
Figure 26. Over The Counter (OTC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Over The Counter (OTC) Drugs Sales Market Share by Type (2015-2020)
Figure 28. Global Over The Counter (OTC) Drugs Sales Market Share by Type in 2019
Figure 29. Global Over The Counter (OTC) Drugs Revenue Market Share by Type (2015-2020)
Figure 30. Global Over The Counter (OTC) Drugs Revenue Market Share by Type in 2019
Figure 31. Global Over The Counter (OTC) Drugs Market Share by Price Range (2015-2020)
Figure 32. Global Over The Counter (OTC) Drugs Sales Market Share by Application (2015-2020)
Figure 33. Global Over The Counter (OTC) Drugs Sales Market Share by Application in 2019
Figure 34. Global Over The Counter (OTC) Drugs Revenue Market Share by Application (2015-2020)
Figure 35. Global Over The Counter (OTC) Drugs Revenue Market Share by Application in 2019
Figure 36. North America Over The Counter (OTC) Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 37. North America Over The Counter (OTC) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 38. North America Over The Counter (OTC) Drugs Sales Market Share by Country in 2019
Figure 39. North America Over The Counter (OTC) Drugs Revenue Market Share by Country in 2019
Figure 40. U.S. Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 41. U.S. Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Canada Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 43. Canada Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. North America Over The Counter (OTC) Drugs Market Share by Type in 2019
Figure 45. North America Over The Counter (OTC) Drugs Market Share by Application in 2019
Figure 46. Europe Over The Counter (OTC) Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 47. Europe Over The Counter (OTC) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 48. Europe Over The Counter (OTC) Drugs Sales Market Share by Country in 2019
Figure 49. Europe Over The Counter (OTC) Drugs Revenue Market Share by Country in 2019
Figure 50. Germany Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 51. Germany Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. France Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 53. France Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. U.K. Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 55. U.K. Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Italy Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 57. Italy Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Russia Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 59. Russia Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Europe Over The Counter (OTC) Drugs Market Share by Type in 2019
Figure 61. Europe Over The Counter (OTC) Drugs Market Share by Application in 2019
Figure 62. Asia Pacific Over The Counter (OTC) Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 63. Asia Pacific Over The Counter (OTC) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 64. Asia Pacific Over The Counter (OTC) Drugs Sales Market Share by Region in 2019
Figure 65. Asia Pacific Over The Counter (OTC) Drugs Revenue Market Share by Region in 2019
Figure 66. China Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 67. China Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Japan Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 69. Japan Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. South Korea Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 71. South Korea Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. India Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 73. India Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Australia Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 75. Australia Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Taiwan Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 77. Taiwan Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Indonesia Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 79. Indonesia Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Thailand Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 81. Thailand Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Malaysia Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 83. Malaysia Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Philippines Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 85. Philippines Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Vietnam Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 87. Vietnam Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Asia Pacific Over The Counter (OTC) Drugs Market Share by Type in 2019
Figure 89. Asia Pacific Over The Counter (OTC) Drugs Market Share by Application in 2019
Figure 90. Latin America Over The Counter (OTC) Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 91. Latin America Over The Counter (OTC) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 92. Latin America Over The Counter (OTC) Drugs Sales Market Share by Country in 2019
Figure 93. Latin America Over The Counter (OTC) Drugs Revenue Market Share by Country in 2019
Figure 94. Mexico Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 95. Mexico Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Brazil Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 97. Brazil Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Argentina Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 99. Argentina Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Latin America Over The Counter (OTC) Drugs Market Share by Type in 2019
Figure 101. Latin America Over The Counter (OTC) Drugs Market Share by Application in 2019
Figure 102. Middle East and Africa Over The Counter (OTC) Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 103. Middle East and Africa Over The Counter (OTC) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 104. Middle East and Africa Over The Counter (OTC) Drugs Sales Market Share by Country in 2019
Figure 105. Middle East and Africa Over The Counter (OTC) Drugs Revenue Market Share by Country in 2019
Figure 106. Turkey Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 107. Turkey Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Saudi Arabia Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 109. Saudi Arabia Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. U.A.E Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 111. U.A.E Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 112. Middle East and Africa Over The Counter (OTC) Drugs Market Share by Type in 2019
Figure 113. Middle East and Africa Over The Counter (OTC) Drugs Market Share by Application in 2019
Figure 114. Bayer AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. GlaxoSmithKline PLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Novartis International AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Pfizer,Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. PGT healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. Sanofi S.A Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 123. North America Over The Counter (OTC) Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 124. North America Over The Counter (OTC) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Europe Over The Counter (OTC) Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 126. Europe Over The Counter (OTC) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Asia Pacific Over The Counter (OTC) Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 128. Asia Pacific Over The Counter (OTC) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Latin America Over The Counter (OTC) Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 130. Latin America Over The Counter (OTC) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 131. Middle East and Africa Over The Counter (OTC) Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 132. Middle East and Africa Over The Counter (OTC) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 133. Porter's Five Forces Analysis
Figure 134. Channels of Distribution
Figure 135. Distributors Profiles
Figure 136. Bottom-up and Top-down Approaches for This Report
Figure 137. Data Triangulation
Figure 138. Key Executives Interviewed
